Rheuma-Research Lausitz, Zentrum für klinische Studien
- Address
- Pücklerstraße 49, 03042 Cottbus, Germany
Immune System Diseases and Musculoskeletal Diseases
At Rheuma-Research Lausitz, Zentrum für klinische Studien, clinical research focuses on inflammatory joint and spine conditions within the fields of immune system and musculoskeletal disease. The studies are designed to better understand how new treatments may help people living with chronic autoimmune arthritis.
- Research in psoriatic arthritis, including active disease, to assess treatment effectiveness and long-term safety
- Studies in rheumatoid arthritis aimed at evaluating how well new therapies control symptoms and disease activity
- Clinical work in radiographic axial spondyloarthritis to test whether investigational therapies improve outcomes for spinal inflammation
- Trials exploring new options for arthritis care, with attention to both safety and symptom relief
The site in Cottbus, Germany contributes to research that may improve treatment choices for people with chronic autoimmune and rheumatic diseases.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Janssen Cilag International1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Rheuma-Research Lausitz, Zentrum für klinische Studien
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JNJ-88545223 in Participants with Active Psoriatic Arthritis | Janssen Cilag International | Phase II | Recruiting | Mar 2026 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Tulisokibart | 1 | Unknown | 2026-05-08 | 2026-05-08 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.